#MedNews: Unapproved #GLP-1 drugs such as retatrutide and zenagamtide are being sold on the black market, raising concerns about questionable quality and safety issues.

#MedNews: As daily alcohol use declines among younger adults, routine #cannabis use is rising.

What are the risks of more frequent use? Read more:

From #EASD2026 - The long-acting amylin analog petrelintide is well tolerated and can achieve clinically and statistically significant weight loss in people with #obesity compared with placebo.

👉️ buff.ly/BlrCa0G

#MedNews

From #EASD2026 - Orforglipron, an oral non-peptide #GLP1 receptor agonist may be a feasible treatment option for patients with type 2 diabetes who are at increased cardiovascular risk.

Full story 👉️ buff.ly/TRkGkce

#MedNews

#MedNews: A ketogenic diet’s liver health benefits outperformed a Mediterranean diet and a low-fat plant-forward diet in a head-to-head trial of people with metabolically unhealthy obesity.

What are the real-world implications?

#MedNews: Children are using #AI chatbots for advice and emotional support.

Should there be safeguards as the tools become more common?

From #EASD2026 - Mauritius has become the first country to demonstrate a decrease in the prevalence of type 2 diabetes and intermediate hyperglycemia using the oral glucose tolerance test.

Full story 👉️ buff.ly/hZM05mX

#MedNews

From #EASD2026 - The first consensus recommendations for the use of #GLP1 receptor agonists during preconception, pregnancy, and the postnatal period in women with diabetes have been published.

Read the full story 👉️ buff.ly/KEfCaam

#MedNews

#MedNews - Nirsevimab is highly effective in preventing severe respiratory syncytial virus disease requiring emergency department visits, hospitalization, or intensive care unit admission.

👉️ buff.ly/4VREL4W

#IDSky #RSV

#MedNews - A phase 1 study has shown initial evidence that A-319, a bispecific T-cell engager, is well tolerated by patients with systemic lupus erythematosus and efficacious.

👉️ buff.ly/Kg5oa0H

#RheumSky #Lupus

#MedNews - Using optical coherence tomography angiography to measure vessel density may detect glaucoma progression earlier than using OCT to determine structural circumpapillary retinal nerve fiber layer thinning or visual field testing.

👉️ buff.ly/HUP5wQm

#EyeSky

#MedNews - Treatment with the novel antibody–drug conjugate tambotatug pelitecan significantly prolongs the survival of patients with small-cell lung cancer that has progressed after first-line therapy.

👉️ buff.ly/wpqFm8Y

#OncSky #SCLC

#MedNews - People with invasive cancer have a significantly higher risk for #stroke than the general population, particularly in the initial 3 months after diagnosis and in those with pancreatic or lung cancer.

Full story 👉️ buff.ly/7KrFWlE

#OncSky

#MedNews - An international panel of experts has proposed a framework for the use of resmetirom and semaglutide in the treatment of patients with #MASH and significant fibrosis but no cirrhosis.

Full story 👉️ buff.ly/lD8hqCm

#LiverSky

#MedNews - The risk for #ketoacidosis varies by patient characteristics among people with type 2 diabetes using #SGLT2 inhibitors and is apparent throughout treatment.

Full story 👉️ buff.ly/bA9G87d

From #ESCCongress 2026: The ACASA-TAVI and NOTION-4 trials have provided conflicting results with regard to the use of direct oral anticoagulants after #TAVI for severe aortic valve stenosis.

👉️ buff.ly/85WZb9Y

#MedNews

#MedNews - Infants hospitalized with #pertussis have more severe outcomes with azithromycin than with clarithromycin.

Full story 👉️ buff.ly/adCP7jF

#IDSky

#MedNews: Could #caffeine be good for the cardiovascular system?

☕🫀 It depends, according to a recent scientific statement from @americanheart.bsky.social.

Here’s the latest evidence:

#MedNews: As more adults seek #ADHD evaluations, primary care clinicians face growing pressure to accurately diagnose and manage the condition.

Find out more about the challenges of distinguishing ADHD from other conditions and how new clinical guidelines may help improve care.

#MedNews - #Tuberculosis preventive treatment significantly reduces TB incidence and all-cause mortality in people with HIV initiating antiretroviral therapy.

👉️ buff.ly/MKLDHgp

#IDSky